Moreover, by identifying DLB through DAT imaging, clinicians can make informed decisions to select antipsychotic medications cautiously, preferably opting for those with minimal dopamine-blocking effects, such as Quetiapine, as mentioned previously. The gene discussed is SLC6A3; the disease is Lewy body dementia.